Wake-up haul: an Ozempic moment for the brain
Summary
This episode explores the pharmaceutical potential of orexin agonists, which may rival GLP-1 drugs in treating narcolepsy and other conditions. It then analyzes Japan’s weak startup ecosystem, citing capital shortages and cultural barriers to unicorn creation. Finally, the hosts discuss the severe financial and health costs of procrastination, offering evidence-based strategies like exercise and mental contrasting to overcome it.
Topics discussed
Orexin agonists: The next big thing in pharma?
Why Japan's startup scene is struggling to produce unicorns
The science of procrastination and how to beat it
Listen ad-free on Castria